Sarah Kavanagh
Vice President, Investor Relations
Replay available
Celldex Therapeutics, Inc. (NASDAQ: CLDX) Q1 2025 earnings conference call, held 2025-06-12. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
Co-Founder, President and Chief Executive Officer
Senior Vice President and Chief Medical Officer
Professor, Dept. of Dermatology and Allergy; Head of Translational Research and Deputy Head of Clinical Trials, Charité University Berlin
Co-Founder, Executive Vice President and Chief Scientific Officer
Analyst, Leerink Partners
Analyst, Cantor Fitzgerald
Analyst, LifeSci Capital
Watch the replay and follow the connected company analysis, news, and investor updates for Celldex Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.075 Hello. Welcome to CELF-DEX conference call and webcast. 00:00:04.075 -- 00:00:07.738 At this time, all participants are in a listen-only mode. 00:00:07.738 -- 00:00:12.202 After the speaker's presentation, there will be a question and answer session. 00:00:12.202 -- 00:00:17.327 To ask the question during the session, you will need to press star 11 on your telephone. 00:00:17.327 -- 00:00:21.210 You will then hear an automated message advising your hand is raised. 00:00:21.210 -- 00:00:23.993 To withdraw your question, please press star 11 again. 00:00:23.993 -- 00:00:27.976 I would now like to turn the conference over to Sarah Kavanagh. 00:00:27.976 -- 00:00:30.256 You may begin. 00:00:30.490 -- 00:00:31.732 Thank you. 00:00:31.732 -- 00:00:35.678 Good evening, and thank you all for joining us to discuss the latest results from our 00:00:35.678 -- 00:00:40.887 Phase 2 Barzavolumab Program in Chronic Spontaneous Cuticaria, or CSU, 00:00:40.887 -- 00:00:45.594 which are being presented tomorrow morning in a late-breaking oral presentation at the 00:00:45.594 -- 00:00:50.702 European Academy of Allergy and Clinical Immunology Congress in Glasgow, Scotland. 00:00:50.702 -- 00:00:54.308 The embargo on the study listed at the start of the call, and this evening we will be 00:00:54.308 -- 00:00:59.647 discussing the data set in full. Joining me on the call today are Anthony Marucci, 00:00:59.647 -- 00:01:02.670 Co-Founder, President, and Chief Executive Officer, Dr. 00:01:02.670 -- 00:01:07.677 Tibor Keller, Co-Founder, Executive Vice President, and Chief Scientific Officer, Dr. 00:01:07.677 -- 00:01:11.682 Diane Young, Senior Vice President and Chief Medical Officer, and Dr. 00:01:11.682 -- 00:01:15.707 Margot Hicciozzi, Senior Vice Pre...